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Abstract
Background: Osteoarthritis of the first metatarsophalangeal joint (1st MTPJ OA) is a common and disabling condition
commonly managed with footwear and orthotic interventions. The objective of this study was to identify factors
associated with a successful treatment response in people with 1st MTPJ OA provided with prefabricated orthoses or
rocker-sole footwear as part of a randomised clinical trial.
Methods: People with 1st MTPJ OA (n = 88) who participated in a randomised trial were allocated to receive
prefabricated foot orthoses (n = 47) or rocker-sole footwear (n = 41) and completed a baseline questionnaire including
information on demographics, anthropometrics, general health, pain characteristics (including the Foot Health Status
Questionnaire [FHSQ] and Foot Function Index [FFI]) and perceptions of the interventions, and a clinical assessment of
foot posture, range of motion, radiographic severity and in-shoe plantar pressures. Adherence was documented using
diaries. At 12 weeks, participants documented their perception of improvement on a 15-point scale. Those reporting at
least moderate improvement on this scale were classified as ‘responders’.
Results: There were 29 responders (62%) in the orthoses group and 16 responders (39%) in the rocker-sole group.
In the orthoses group, responders had greater baseline pain severity while walking, a higher FFI difficulty score, and
wore their orthoses more frequently. In the rocker-sole group, responders had a higher FFI stiffness score and
greater radiographic severity. However, the accuracy of these variables in identifying responders in each group was
modest (62 and 53%, respectively).
Conclusion: The response to prefabricated orthoses or rocker-sole footwear in people with 1st MTPJ OA is related to
measures of increased pain and disease severity. However, the overall classification accuracy associated with these
factors is not sufficient for identifying individuals who are most likely to benefit from these interventions.
Trial registration: Australian New Zealand Clinical Trials Registry: ACTRN12613001245785
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Background
Osteoarthritis (OA) of the first metatarsophalangeal joint
(1st MTPJ) is the most common presentation of foot
OA, affecting 7.8% of people aged over 50 years [1]. The
condition is characterised by symptoms of joint pain and
stiffness, formation of a dorsal exostosis, and progressive
reduction in range of motion of the 1st MTPJ [2]. People
affected by 1st MTPJ OA report associated locomotor
disability [1] and decreased health-related quality of life
[3]. Commonly recommended treatments for 1st MTPJ
OA include physical therapies, anti-inflammatory medi-
cations, intra-articular injections, foot orthoses, footwear
modifications and surgery [4]. However, few of these
treatments have been rigorously evaluated [5].
In a recent trial, we found that prefabricated foot orth-
oses and rocker-sole footwear were similarly effective at
reducing pain associated with 1st MTPJ OA [6]. How-
ever, the footwear group exhibited lower adherence, re-
ported less global improvement in symptoms, and were
more likely to experience adverse events compared to
the orthoses group. Furthermore, although biomechan-
ical analyses indicated that both interventions reduced
peak pressure under the 1st MTPJ, they appeared to
achieve this through different mechanisms, with the
orthoses increasing pressure under the midfoot and
lesser toes and the rocker-sole footwear decreasing pres-
sure under the 2nd to 5th MTPJs [7].
The findings of our trial suggest that although both
treatments appear to be effective, their acceptability and
underlying mechanisms of action may differ. As such,
there may be some value in identifying the characteris-
tics of those who are most likely to respond favourably
to each treatment, as this could potentially aid in the
clinical decision making process. Previous studies of
non-surgical treatments for musculoskeletal disorders
(such as knee and hip OA and patellofemoral pain) have
shown that a wide range of factors may influence clinical
outcomes, including age, sex, body mass index, pain se-
verity and duration, structural foot characteristics and
range of motion [8–10]. However, no such studies have
been undertaken for foot disorders in general, or 1st
MTPJ OA specifically.
Therefore, the aim of this study was to identify factors
associated with a successful treatment response in
people with 1st MTPJ OA who were provided with pre-
fabricated orthoses or rocker-sole footwear in the trial.
We considered demographics, anthropometrics, general
health, pain characteristics, perceptions of the interven-
tions, structural foot characteristics, radiographic sever-
ity and in-shoe plantar pressures as possible predictors.
Methods
The data presented in this paper are taken from a larger
randomised trial (Australian New Zealand Clinical Trials
Registry ID: ACTRN12613001245785). The La Trobe
University Human Ethics Committee provided ethical
approval (number 13-003) and all participants provided
written informed consent prior to enrolment. The full
trial protocol, including detailed inclusion and exclu-
sion criteria, has been published previously [11]. Key
components of the methods are reproduced in the fol-
lowing section.
Participants
To be included in the study, participants had to have
pain rated at least 20 mm on a 100 mm visual analogue
scale (VAS) in the 1st MTPJ on most days for at least
12 weeks, and less than 64° of dorsiflexion range of
motion of the 1st MTPJ [12]. Although radiographs were
obtained to document the presence and severity of
osteoarthritic changes (see ‘Questionnaires and clinical
assessments’ section below), radiographic signs of OA
were not an inclusion criterion. Key exclusion criteria in-
cluded previous surgery on the 1st MTPJ, significant de-
formity of the 1st MTPJ including hallux valgus [13, 14],
cognitive impairment (a score of <7 on the Short Port-
able Mental Status Questionnaire) [15], and older people
with a history of recurrent falls, due to the short-term
detrimental effects of rocker-sole shoes on balance [16].
Questionnaires and clinical assessments
At baseline, participants completed a comprehensive
questionnaire, clinical assessment and biomechanical as-
sessment, which collected information on the following:
(i) demographics/anthropometrics: age, sex and body
mass index (BMI);
(ii) general health/physical activity: the Short-Form-12
Version 2 questionnaire [17] and the Incidental and
Planned Activity Questionnaire [18];
(iii)pain characteristics: pain duration (months), pain
severity at rest and while walking, stiffness in the
morning and later in the day (each via a 100 mm
visual analog scale), the pain and function subscales
of the the Foot Health Status Questionnaire (FHSQ)
[19], and the pain, difficulty and stiffness subscales of
the the Foot Function Index - Revised (Short Form)
(FFI) [20];
(iv) foot posture and range of motion: the Foot Posture
Index [21] and passive non-weightbearing dorsiflex-
ion range of motion at the 1st MTPJ [22];
(v)radiographic severity of 1st MTPJ OA: using a
standardised radiographic atlas [23], participants
were divided into four radiographic severity groups
(none = no radiographic evidence of OA, mild = at
least one score of one for either osteophytes or joint
space narrowing in either the dorso-plantar or lateral
views, moderate = at least one score of two for either
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osteophytes or joint space narrowing in either the
dorso-plantar or lateral views, or severe = at least
one score of three for either osteophytes or joint
space narrowing in either the dorsoplantar or lateral
views) [2];
(vi) biomechanical effects of the interventions: in-shoe
peak plantar pressures (kPa) were assessed with the
in-shoe Pedar® system (Novel GmbH, Munich,
Germany) when participants were wearing their
own shoes and the intervention, and the percentage
change in peak pressure beneath the 1st MTPJ was
documented;
(vii)credibility and expectancy: the Credibility/Expectancy
Questionnaire (CEQ) [24], which consists consists of
six items: three related to credibility and three related
to expectancy. For each item, participants were asked
to rate the credibility of the treatment and their
expectations on a 9-point Likert scale;
(viii) footwear perceptions: participants allocated to the
rocker-sole footwear group were asked to report
their perceptions of shoe attractiveness (to self and
to others), comfort, ease of donning and doffing, fit
and heaviness, using questions selected from the
Monitor Orthopaedic Shoes questionnaire [25],
scored on a 100 mm visual analog scale. The selected
questions were: (i) Please mark on the following line
how attractive you think the shoes are (with the
anchors “extremely unattractive” and “extremely
attractive”), (ii) Please mark on the following line
how attractive you think other people would think the
shoes are (with the anchors “extremely unattractive”
and “extremely attractive”), (iii) Please mark on the
following line how comfortable you think the shoes
are (with the anchors “extremely uncomfortable” and
“extremely comfortable)”, (iv) Please mark on the
following line how well you think the shoes fit you
(using the anchors “poorest fit possible” and “best fit
possible”), (v) Please indicate how easy it is for you to
don the shoes on and off (using the anchors “most
difficult as possible” and “as easy as imaginable”) and
(vi) Please indicate how heavy the shoes are (using the
anchors “extremely light” and “extremely heavy”);
(ix) adherence: total hours the intervention was worn
over the 12 week follow-up period.
Interventions
The prefabricated foot orthoses group received a pair of
foot orthoses (Vasyli Customs Medium Density, Vasyli
Medical™, Queensland, Australia) that were modified
using a similar approach to that described by Welsh et
al. [26], involving the addition of a cut-out section be-
neath the first metatarsal and trimming the distal edge
to the level of the 2nd to 5th toe sulci (Fig. 1). In partici-
pants with pronated feet (a Foot Posture Index [FPI]
score of >7 [27]), full length 4-degree medial (varus)
wedges were applied to orthoses until there was a reduc-
tion in the FPI score of at least 2 points [26]. This was
required for 2 participants.
The rocker-sole footwear group were provided with
a pair of MBT® shoes (Masai Barefoot Technology,
Switzerland) (Fig. 2) [28]. Four participants received
the Mahuta model and 42 received the Matwa model,
as the Mahuta was discontinued shortly after study
commencement. However, both models had the same
sole curvature and only differed in relation to the
aesthetics of the upper.
Definition of responders and non-responders
At the 12 week follow-up, participants documented their
perception of overall improvement on a 15-point scale
using the descriptors “a very great deal better” (score = 7),
“a great deal better” (score = 6), “a good deal better” (score
= 5), “moderately better” (score = 4), “somewhat better”
(score = 3), “a little better” (score = 2), “about the same,
hardly any better at all” (score = 1), “no change” (score =
Fig. 1 Prefabricated foot orthoses used in the trial. Top: plantar surface
of left foot orthosis. Bottom: dorsal surface of right foot orthosis. Figure
from Menz et al. [8]
Fig. 2 MBT® Matwa footwear used in the trial. Figure from Menz et al. [8]
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0), “about the same, hardly any worse at all” (score = −1),
“a little worse (score = −2), “somewhat worse” (score =
−3), “moderately worse” (score = −4), “a good deal worse”
(score = −5), “a great deal worse” (score = −6) and “a very
great deal worse” (score = −7) [29]. Those reporting a
score of 4 or above (i.e. at least “moderately better”) were
defined as responders, while those reporting a score of less
than four were defined as non-responders.
Statistical analysis
Statistical analysis was undertaken using SPSS version
22.0 (IBM Corp, NY, USA). The most symptomatic foot
was selected as the index foot for all analyses, or in the
case of equivalent symptoms in both feet, the right foot
was selected. All data were explored for normality using
the skewness statistic (−1 to 1). Comparisons between
responders and non-responders within each intervention
group were compared using chi-square tests (for categor-
ical data), independent samples t-tests (for normally dis-
tributed continuous data) or Mann-Whitney U tests (for
skewed continuous data). Variables found to be signifi-
cantly different between responders and non-responders
(at p < 0.05) were then entered into a discriminant func-
tion analyses using the ‘enter’ method. The relative
importance of each variable in discriminating between re-
sponders and non-responders was determined using stan-
dardised canonical discriminant function coefficients.
After deriving each discriminant function, cross-validation
was carried out using the jack-knife procedure, and the
accuracy of the model in identifying responders in each
group was expressed as a percentage [30].
Results
Participants
A total of 102 participants were randomised into the main
study [6]. Complete baseline and 12 week follow-up data
for this analysis were available from 88 participants (47 in
the orthoses group and 41 in the rocker-sole footwear
group). Of these, 29 (62%) were classified as responders in
the orthoses group and 16 (39%) were classified as re-
sponders in the rocker-sole footwear group.
Differences between responders and non-responders in
the orthoses group
In the orthoses group, there were no differences between
responders and non-responders in relation to demo-
graphics/anthropometrics, general health, foot posture
and range of motion, radiographic severity, the biomech-
anical effects of the interventions or treatment credibility
and expectancy. However, responders exhibited greater
baseline pain severity while walking, a higher FFI diffi-
culty score, and wore their orthoses more frequently
than non-responders (see Table 1).
Differences between responders and non-responders in
the rocker-sole footwear group
In the rocker-sole footwear group, there were no differ-
ences between responders and non-responders in rela-
tion to demographics/anthropometrics, general health,
foot posture and range of motion, the biomechanical
effects of the interventions, credibility and expectancy,
adherence or footwear perceptions. However, responders
had a higher FFI stiffness score and greater radiographic
severity than non-responders (see Table 2).
Discriminant function analysis
Results of the discriminant function analysis are shown
in Table 3. In the orthoses group, the discriminant func-
tion model was significant (p = 0.012), and the combin-
ation of three predictor variables identified responders
with 73% accuracy (62% following validation). In the
footwear group, the discriminant function model did not
reach statistical significance (p = 0.175), and the combin-
ation of two predictor variables identified responders
with 63% accuracy (53% following validation).
Discussion
The objective of this study was to identify factors associ-
ated with a successful treatment response in people with
first metatarsophalangeal joint osteoarthritis (1st MTPJ
OA) who were provided with prefabricated orthoses or
rocker-sole footwear as part of a recently completed
randomised clinical trial [6]. To do this, we administered
a comprehensive baseline questionnaire and clinical
assessment (including measures of demographics, an-
thropometrics, general health, pain characteristics, per-
ceptions of the interventions, foot posture, range of
motion, radiographic severity and in-shoe plantar pres-
sures) and compared these characteristics between those
who did and did not respond to each of the interven-
tions at 12 weeks of follow up. We found that several
measures of pain and disease severity differed between
responders and non-responders. However, the ability of
these measures to accurately discriminate between the
groups was only modest.
In the orthoses group, responders had greater baseline
pain severity while walking and a higher FFI difficulty
score, while in the rocker-sole group, responders had a
higher FFI stiffness score and greater radiographic sever-
ity. Taken together, these findings suggest that both
interventions may be more effective in those with more
severe symptoms or more advanced disease. These ob-
servations are consistent with previous studies of OA
affecting the knee or hip. Greater baseline pain severity
has been shown to predict better outcomes of rehabilita-
tion for knee [8] and hip OA [9], while greater radio-
graphic severity is associated with better outcomes
following knee and hip replacement surgery [31–34].
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These findings also add some support to the proposed
biomechanical effects of these interventions, as the vari-
ables found to differ between responders and non-
responders related primarily to functional limitation of
the 1st MTPJ (eg: pain while walking rather than at rest,
and FFI items indicative of difficulty with ambulation).
The only other significant predictor of response we
found was intervention adherence, with responders in
the orthoses group wearing their intervention for a sig-
nificantly greater number of hours throughout the
course of the trial than non-responders. No such differ-
ence was found in the rocker-sole footwear group,
Table 1 Characteristics of non-responders and responders in the orthoses group (n = 47)
Non-responders (n = 18) Responders (n = 29)
Demographics/anthropometrics
Age, years–mean (SD) 59.0 (11.3) 57.1 (10.0)
Females–n (%) 8 (44) 18 (62)
Body mass index, kg/m2–mean (SD) 27.9 (5.1) 29.6 (4.72)
General health/physical activity
SF 12 physical component score–mean (SD) a 43.2 (12.1) 45.2 (10.2)
SF 12 mental component score–mean (SD) a 57.1 (9.5) 54.4 (6.5)
Physical activity, total hours per week–mean (SD) 20.9 (10.5) 17.1 (17.2)
Pain characteristics
Pain duration, months–median (IQR) 33 (101) 30 (59)
Pain severity at rest–mean (SD) b 3.1 (3.0) 3.4 (2.3)
Pain severity while walking–mean (SD) b 3.8 (2.3) 5.2 (2.1)*
Stiffness in the morning–mean (SD) b 2.4 (2.4) 3.6 (2.8)
Stiffness later in the day–mean (SD) b 2.3 (2.7) 3.9 (2.7)
FHSQ pain–mean (SD) a 61.5 (23.4) 53.5 (17.6)
FHSQ function–mean (SD) a 77.1 (18.6) 66.2 (24.8)
FFI pain–mean (SD) a 34.8 (15.6) 44.8 (17.9)
FFI difficulty–mean (SD) a 26.9 (20.2) 43.9 (26.3)*
FFI stiffness–mean (SD) a 28.1 (18.7) 36.7 (20.8)
Pain Catastrophising Scale–mean (SD) b 8.2 (7.8) 10.0 (8.9)
Foot posture and range of motion
Foot posture index–mean (SD) 2.9 (2.7) 2.9 (2.4)
1st MTPJ range of motion (°)–mean (SD) 41.2 (12.6) 40.3 (11.7)
Radiographic severity
None–n (%) 0 (0) 0 (0)
Mild–n (%) 3 (17) 12 (41)
Moderate–n (%) 7 (39) 6 (21)
Severe–n (%) 8 (44) 11 (38)
Biomechanical effects of intervention
1st MTPJ peak pressure: own shoes, kPa–median (IQR) 188.8 (100.0) 150.0 (60.0)
1st MTPJ peak pressure: intervention, kPa–median (IQR) 161.3 (68.8) 125.0 (70.0)
% reduction in 1st MTPJ peak pressure–median (IQR) 14.0 (24.7) 13.6 (16.3)
Credibility and Expectancy Questionnaire
Credibility–mean (SD) 19.6 (2.4) 21.2 (3.2)
Expectancy–mean (SD) 17.3 (3.4) 16.9 (4.1)
Total hours intervention worn during study–mean (SD) 332 (202) 518 (245)*
SD standard deviation, IQR interquartile range
alower scores indicate worse health status/greater impairment
bhigher scores indicate worse health status/greater impairment
*p < 0.05
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Table 2 Characteristics of non-responders and responders in the rocker-sole footwear group (n = 41)
Non-responders (n = 25) Responders (n = 16)
Demographics/anthropometrics
Age, years–mean (SD) 56.9 (8.4) 55.9 (12.4)
Females–n (%) 14 (56) 11 (69)
Body mass index, kg/m2–mean (SD) 28.4 (4.1) 28.3 (4.9)
General health/physical activity
SF 12 physical component score–mean (SD) a 45.8 (10.2) 45.4 (9.8)
SF 12 mental component score–mean (SD) a 52.2 (8.1) 51.7 (10.8)
Physical activity, total hours per week–mean (SD) 14.5 (11.0) 16.8 (10.1)
Pain characteristics
Pain duration, months–median (IQR) 36 (108) 24 (75)
Pain severity at rest–mean (SD) b 3.4 (2.7) 3.5 (2.3)
Pain severity while walking–mean (SD) b 4.7 (2.2) 5.1 (2.1)
Stiffness in the morning–mean (SD) b 3.9 (2.9) 4.1 (1.6)
Stiffness later in the day–mean (SD) b 3.7 (2.8) 3.7 (2.2)
FHSQ pain–mean (SD) a 52.6 (19.7) 45.9 (17.9)
FHSQ function–mean (SD) a 70.8 (23.4) 62.5 (28.0)
FFI pain–mean (SD) a 41.1 (16.6) 47.1 (18.3)
FFI difficulty–mean (SD) a 37.2 (25.3) 45.9 (23.3)
FFI stiffness–mean (SD) a 31.8 (22.9) 44.4 (16.7)*
Pain Catastrophising Scale–mean (SD) b 9.2 (6.9) 10.6 (7.9)
Foot posture and range of motion
Foot posture index–mean (SD) 3.5 (2.0) 3.6 (2.2)
1st MTPJ range of motion (°)–mean (SD) 41.4 (13.4) 38.5 (13.8)
Radiographic severity
None–n (%) 1 (4) 3 (20)
Mild–n (%) 3 (13) 2 (13)
Moderate–n (%) 16 (70) 2 (13)
Severe–n (%) 3 (13) 8 (53)*
Biomechanical effects of intervention
1st MTPJ peak pressure: own shoes, kPa–mean (SD) 167.5 (62.5) 158.3 (40.6)
1st MTPJ peak pressure: intervention, kPa–mean (SD) 133.2 (49.1) 137.3 (36.8)
% reduction in 1st MTPJ peak pressure 19.5 (18.0) 11.2 (19.8)
Credibility and Expectancy Questionnaire
Credibility–mean (SD) 21.0 (3.6) 21.3 (3.3)
Expectancy–mean (SD) 17.1 (5.3) 19.1 (4.4)
Footwear perceptions (100 mm visual analog scales)
Shoe attractiveness (to self)–mean (SD) 40.1 (20.4) 50.7 (26.3)
Shoe attractiveness (to others)–mean (SD) 38.4 (20.7) 48.7 (21.8)
Shoe comfort–mean (SD) 61.6 (26.6) 64.3 (18.5)
Ease of donning and doffing shoes–mean (SD) 76.6 (21.1) 79.6 (16.5)
Perception of shoe fit–median (IQR) 82.0 (21.0) 77.5 (16.0)
Perception of shoe heaviness–mean (SD) 46.1 (25.2) 44.7 (18.7)
Total hours intervention worn during study–mean (SD) 278 (200) 320 (179)
SD standard deviation, IQR interquartile range
alower scores indicate worse health status/greater impairment
bhigher scores indicate worse health status/greater impairment
*p < 0.05
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although the overall adherence in this group was sub-
stantially lower, possibly due to aesthetic concerns about
the footwear and workplace attire constraints. Although
no studies have explored the role of adherence in pre-
dicting outcomes of footwear-related interventions in
foot OA, it has previously been shown that greater ad-
herence with prescribed footwear is associated with a
lower rate of foot ulcer recurrence in people with dia-
betic peripheral neuropathy [35, 36]. However, given that
adherence was documented throughout the trial, it is
also possible that adherence increased as a consequence
of reduction in pain in some individuals, rather than be-
ing a cause of pain reduction.
The current biomechanical theory underpinning the
use of mechanical interventions for 1st MTPJ OA
would suggest that those with greater range of motion
may be more likely to benefit from orthoses, as the re-
moval of material beneath the 1st MTPJ would facilitate
first ray plantarflexion during propulsion, thereby
allowing the proximal phalanx to rotate on the first
metatarsal head to achieve sufficient 1st MTPJ dorsi-
flexion [37]. In contrast, those with less range of mo-
tion may be more likely to benefit from the rocker-sole
footwear, as the curved sole reduces the need for 1st
MTPJ dorsiflexion during propulsion [38]. However,
neither the range of motion of the 1st MTPJ, nor the
changes in 1st MTPJ plantar pressure associated with
the interventions differed between responders and non-
responders in either group. This may be because the
available 1st MTPJ range of motion measured when
non-weightbearing is only moderately associated with
the range used during gait [39], and that vertical pres-
sures may not provide a valid indicator of compressive
forces within the 1st MTPJ.
This study has a number of limitations. Firstly, we
were unable to use the OMERACT-OARSI criteria [40]
to define responders, as these criteria are based on
Western Ontario McMaster Universities Osteoarthritis
(WOMAC) index scores in people with hip or knee
OA. In the absence of any established criteria to define
responders in foot OA, we consider our cut-off score
(at least “moderately better” on a 15-point scale) to be
justifiable, but acknowledge that this is essentially arbi-
trary. Secondly, although we included a broad array of
potential predictor variables, we acknowledge that
other measures may have provided additional insights.
For example, direct measurement of 1st MTPJ kinemat-
ics and kinetics using a marker-based optoelectronic
gait analysis system may have provided greater insight
into changes in joint function, however this was not
possible in our trial as it would have required perman-
ent modification of the participants’ footwear to accom-
modate the markers. A more objective measure of
adherence (such as using a wearable sensor [41]) would
also have been useful. Thirdly, we were unable to in-
clude a non-treatment control arm in this trial, so we
cannot exclude the contribution of contextual effects to
the apparent improvements in both treatment groups.
Finally, although we identified several factors which dif-
fered between responders and non-responders, the
discriminant function analysis indicated that the classi-
fication accuracy was modest and unlikely to be suffi-
cient for identifying patients who are most likely to
respond in a clinical setting.
Conclusion
People with 1st MTPJ OA who responded favourably to
prefabricated orthoses had more baseline pain and diffi-
culty walking, and wore their orthoses more frequently
during the trial, while those who responded favourably
to rocker-sole footwear had greater baseline joint stiff-
ness and radiographic OA severity. However, the overall
classification accuracy associated with these factors was
modest and is unlikely to be sufficient for identifying re-
sponders in a clinical setting. Further study is therefore
required to identify factors that predict a positive treat-
ment response to treatments for 1st MTPJ OA.
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